2-Pyrrolecarbaldehyde

Why Is Strict Control of 2‑Pyrrolecarbaldehyde Purity Critical in Pyrrolotriazine Nucleoside Synthesis?

In the production of the pyrrolo[2,1‑f][1,2,4]triazin‑4‑amine core, which constitutes the heterocyclic scaffold of the antiviral prodrug remdesivir and several investigational nucleotide analogues, 2‑pyrrolecarbaldehyde serves as the C‑2 aldehyde‑bearing building block. Industry data from pilot‑scale campaigns involving 200‑L glass‑lined reactors indicate that the cyclocondensation with aminoguanidine hydrochloride or a protected 1,2,4‑triazole‑3‑thioamide requires the aldehyde to be added at a precisely maintained temperature of −5 °C to 0 °C; excursions beyond +2 °C during the exothermic charge generate a bis‑pyrrole adduct impurity that co‑crystallises with the target triazine, reducing isolated purity to 98.1% from a baseline of 99.7% (HPLC area, 254 nm). The molar ratio adopted for this step is 1 : 1.05 (aldehyde : aminonitrile component) in acetonitrile with phosphorus oxychloride catalyst at 2.2 equiv, followed by an aqueous quench at ≤ 8 °C to suppress hydrolysis reverting the product. Strict adherence to ICH Q3A(R2) for unspecified impurities (≤ 0.10%) and ICH Q3C(R8) for residual acetonitrile (class 2, limit 410 ppm) governs the acceptance criteria for the isolated intermediate. Residual 3‑pyrrolecarbaldehyde isomer, a commercially common contaminant, must be controlled at ≤ 0.15% since it propagates through the synthetic sequence to yield a regioisomeric nucleobase that is inseparable in the final preparative SFC purification of the active pharmaceutical ingredient. Downstream steps — Vilsmeier‑Haack chlorination at the 4‑position of the triazine with POCl₃/PhNMe₂ at 80 °C for 6 h, ammonia displacement in a Hastelloy C‑22 pressure vessel at 4.5 bar and 110 °C, and regioselective iodination — are all monitored for mass balance against the initial aldehyde charge. Finished dosage forms of the coupled nucleotide prodrug are governed by the Ph. Eur. monograph and USP <232>/<233> elemental impurity limits, with particular attention to palladium (≤ 10 µg/g) carried from Sonogashira coupling.

BODIPY Dyes and the Aldehyde‑to‑Dipyrromethene Pathway

2‑Pyrrolecarbaldehyde enters the synthesis of 4,4‑difluoro‑4‑bora‑3a,4a‑diaza‑s‑indacene (BODIPY) fluorophores via a two‑pot condensation‑oxidation‑complexation cascade that is extremely susceptible to oligomerisation unless the initial dipyrromethene stage is arrested. On a 20‑L automated reactor train equipped with a turbidity probe, the aldehyde (1.0 equiv) is reacted with a 2,4‑dimethyl‑3‑ethyl‑pyrrole derivative (2.05 equiv) in dichloromethane under trifluoroacetic acid catalysis (0.1 equiv) at 20–22 °C for 45 min; oxidation with 2.1 equiv of 2,3‑dichloro‑5,6‑dicyano‑1,4‑benzoquinone (DDQ) is then performed at ≤ 10 °C, with conversion monitored by absorbance at 520 nm. Immediate complexation with boron trifluoride diethyl etherate (3.0 equiv) in the presence of N,N‑diisopropylethylamine (5.5 equiv) at 55 °C locks the chromophore. Flash chromatographic purification on a Biotage® Sfär HC silica column (particle size 20 µm, load ratio 1 : 40) with a heptane/ethyl acetate gradient isolates the dye at a typical recovery of 76–82% of theory. Commercial specifications for REACH‑registered BODIPY derivatives that are destined for fluorescence‐activated cell sorting (FACS) reagent kits reference ISO 10993‑1:2018 biocompatibility for indirect patient contact and mandate a fluorescent quantum yield Φ_F of ≥ 0.82 as measured by the absolute method in an integrating sphere under air‑equilibrated methanol (excitation 488 nm), per a modified IUPAC guideline. End‑use products span lipid droplet probes (ex/em 505/515 nm), thiol‑reactive maleimide‑conjugated dyes for super‑resolution microscopy, and solid‑state luminescent solar concentrators where the dye is blended into a PMMA matrix at 0.05–0.2 wt% before thermoplastic extrusion at 220 °C. Tabulated below are the critical quality attributes for two BODIPY grades derived from 2‑pyrrolecarbaldehyde, illustrating the property cliff‑edge when monomer purity drops below 99.0%.

Cyanation of 2‑Pyrrolecarbaldehyde Delivers the Phenotypic Phenylpyrrole Fungicide Intermediate

For the non‑systemic phenylpyrrole fungicides fludioxonil and fenpiclonil, the electron‑withdrawing cyano group at the pyrrole 3‑position is installed by dehydrating the aldoxime derived from 2‑pyrrolecarbaldehyde. A validated synthesis line at a dedicated agrochemical active ingredient facility processes the aldehyde in 2,500‑L rubber‑lined mild‑steel vessels: an aqueous slurry of hydroxylamine hydrochloride (1.15 equiv) and sodium carbonate (1.25 equiv) is charged at 25 °C, the aldehyde is pumped in at a rate of 8 L·min⁻¹, and the oximation is completed within 30 min at 40 °C. After phase separation, the organic‑phase oxime is subjected to acetic anhydride‑mediated dehydration (1.4 equiv) under reflux at 115–120 °C for 2 h, producing 2‑cyanopyrrole in 92% distilled yield (b.p. 97–99 °C at 15 mmHg). The reaction mass is quenched into chilled water; failure to maintain quench temperature below 20 °C precipitates a viscous, dark cyanohydrin side product that fouls the short‑path wiped‑film evaporator and increases vacuum pump maintenance intervals by a factor of three. The intermediate must comply with the active substance purity specification set out in FAO 304/TC (2006) for fludioxonil technical, which demands a cyanide content ≤ 0.03% and a 2‑pyrrolecarbaldehyde carry‑over ≤ 0.2%. Downstream, the cyanopyrrole is coupled with 2,2‑difluoro‑1,3‑benzodioxole‑4‑boronic acid via Suzuki‑Miyaura reaction in tetrahydrofuran/water at 65 °C using Pd(PPh₃)₄ at 0.5 mol% to build the fludioxonil core. Terminal formulations include 25 g/L flowable seed treatment suspensions meeting CIPAC MT 184 suspension stability and 4 g/kg granular in‑furrow treatments; the AI loading is determined by the cyanopyrrole purity, as any unconverted aldehyde leads to phytotoxic pyrazine by‑products during seedling imbibition.

In a Grignard‑mediated acetylation protocol utilised by FEMA‑compliant flavour ingredient manufacturers, 2‑pyrrolecarbaldehyde is converted to 2‑acetylpyrrole (FEMA 3202, JECFA 1010) via methylmagnesium chloride addition followed by Oppenauer oxidation. The aldehyde is dissolved in anhydrous tetrahydrofuran (water specification by Karl Fischer ≤ 50 ppm) and cooled to −15 °C; a 3 M solution of CH₃MgCl in THF (1.2 equiv) is metered in over 60 min while maintaining the jacket temperature at −20 °C. After 1 h of ageing, the resulting alkoxide is transferred to a second vessel containing aluminium isopropoxide (0.15 equiv) and acetone (4.0 equiv) in toluene held at 65 °C for the Oppenauer oxidation; yield of isolated 2‑acetylpyrrole after vacuum distillation (b.p. 82–84 °C/5 mmHg) is 78–82% with a sensory grade purity of ≥ 99.0% (GLC). EU compliance with Regulation 1334/2008 requires GC‑MS profiling to ensure the absence of the mutagenic pyrrole‑2‑carboxylate ester isomer above the Threshold of Toxicological Concern of 1.5 µg/day for a 60 kg adult. The acetylpyrrole is subsequently incorporated into compounded liquid bakery flavours and roasted nut reactor process flavours at concentrations between 5 ppm and 35 ppm in the finished confectionery matrix, whereas dry blending in savoury seasoning bases for extrusion‑puffed snacks is limited to 4–12 mg/kg due to volatility loss during the hot‑oil frying step. Stainless‑steel 316L batch rectification columns with structured packing of 1.5 m height are recommended to achieve the olfactory purity required by the International Organisation of the Flavor Industry (IOFI) monograph.

When 2‑Pyrrolecarbaldehyde‑Derived Schiff Bases Inhibit Uniform Corrosion in Acidic Media

Schiff bases synthesised from 2‑pyrrolecarbaldehyde and aliphatic or aromatic primary amines are employed as mixed‑type inhibitors for carbon‑steel corrosion in hydrochloric acid pickling baths, with performance validated through gravimetric and electrochemical methods conforming to ASTM G31‑72 (immersion testing at 30 °C ± 1 °C, 24‑h exposure) and potentiodynamic polarisation per ASTM G59‑97. In plant trials conducted on API 5L X52 pipeline steel coupons, an ethanol‑soluble bis‑Schiff base derived from 2‑pyrrolecarbaldehyde and 1,2‑diaminobenzene was dosed into 15% HCl at concentrations of 0.5 mM to 5.0 mM. Inhibition efficiency plateaued at 96.3% at 3.0 mM, beyond which the formation of an excessively thick adsorbed organic film on the metal surface retarded heat transfer during post‑pickling rinse cycles by 22 seconds in automated rack lines, as recorded by the bath‑integrated thermal probe. The ligand is manufactured by mixing 2‑pyrrolecarbaldehyde (2.05 equiv) and the diamine (1.00 equiv) in absolute ethanol at reflux for 90 min, followed by precipitation in deionised water and vacuum drying at 50 °C. Relevant occupational health standards during blending of the inhibitor into the working pickle liquid are governed by European Chemical Agency risk assessment RAC‑54/2018 for hydrogen halide emissions, while the finished inhibited acid blend is classified under CLP Regulation (EC 1272/2008) with H290 and H314 hazard statements. Original equipment manufacturers applying this chemistry in continuous coil descaling lines specify a dosage window of 2.5–4.0 mM, beyond which the adsorbed inhibitor layer interferes with the subsequent surface‑activation step of the zinc phosphate conversion coating.

Current hole‑transport materials for perovskite solar cells demand dopants with optimised redox potentials; a class of such dopants features bis(2‑pyrrolyl)methane ligands obtained from the condensation of 2‑pyrrolecarbaldehyde with pyrrole under acidic catalysis. In a typical ligand synthesis procedure scaled to a 10‑L cylindrical borosilicate reactor, pyrrole (2.1 equiv) and 2‑pyrrolecarbaldehyde (1.0 equiv) are charged in methanol and treated with catalytic methanesulfonic acid (0.08 equiv) at 0 °C under an argon blanket; the exotherm must be controlled within ±3 °C to avoid the formation of tripyrrane oligomers that precipitate as a tarry mass and block the bottom‑outlet valve. The resulting dipyrromethane ligand is isolated by ethyl acetate extraction and complexed with cobalt(III) or copper(II) acetate in refluxing methanol to yield the p‑dopant complex. When blended into a standard 2,2′,7,7′‑tetrakis‑(N,N‑di‑p‑methoxyphenylamine)‑9,9′‑spirobifluorene (spiro‑OMeTAD) hole‑transport layer formulation, the dipyrromethane‑based dopant is incorporated at 0.3–1.0 wt% relative to the organic semiconductor, with spin‑coating performed inside a nitrogen‑filled glovebox (O₂ and H₂O both <0.1 ppm) at 3,000 rpm for 30 s on ITO‑coated glass. Photovoltaic module manufacturer acceptance tests for such doped layers reference the IEC 61215‑1‑4:2022 standard for thermal‑cycle durability (200 cycles, −40 °C to +85 °C) and RoHS Directive 2011/65/EU exemption 7(c)‑IV for lead‑containing perovskite absorbers, while the intermediate ligand powder is registered under REACH as a non‑phase‑in substance with a total annual tonnage band of 1–10 t. Nuclear magnetic resonance monitoring of the condensation at intervals of 15 min is advised because the acid‑sensitive aldehyde can undergo Cannizzaro‑type disproportionation at pH < 1, consuming the starting material and producing the inactive 2‑pyrrolemethanol and pyrrole‑2‑carboxylate species that degrade device fill factor by more than 15%.